Description

PIPTASIGN Injection is a potent broad-spectrum β-lactam/β-lactamase inhibitor combination that consists of Piperacillin (a ureidopenicillin antibiotic) and Tazobactam (a β-lactamase inhibitor). This synergistic formulation enhances the activity of Piperacillin by preventing bacterial resistance mechanisms, particularly against organisms producing β-lactamase enzymes.

PIPTASIGN is widely used in the treatment of moderate to severe bacterial infections, including those of the respiratory tract, urinary tract, intra-abdominal area, skin and soft tissues, and gynecological infections. It is also commonly administered in cases of hospital-acquired infections, neutropenic fever, and sepsis.

This injection is manufactured under WHO-GMP, ISO, and stringent regulatory standards by BLUEPILL EXPRESS, a trusted global pharmaceutical manufacturer and exporter. The company offers PIPTASIGN Injection for third-party manufacturing, international distribution, and custom-label partnerships.

• Broad-Spectrum Antibiotic

• Anti-infective

• β-lactam/β-lactamase Inhibitor Combination

• Piperacillin: 4 g

• Tazobactam: 0.5 g

• Also available in 2.25 g and 1.125 g strengths (on request)

• Effective against resistant gram-positive and gram-negative bacteria

• Inhibits β-lactamase enzymes, enhancing antibiotic spectrum

• Ideal for life-threatening infections in ICU and hospital settings

• Reliable treatment for both aerobic and anaerobic pathogens

• Injectable dosage ensures rapid systemic availability

• Community-acquired and hospital-acquired pneumonia

• Severe urinary tract infections (UTIs)

• Intra-abdominal infections (including peritonitis)

• Pelvic inflammatory disease

• Complicated skin and soft tissue infections

• Febrile neutropenia

• Sepsis and bacteremia

• Adults: Typically 4.5 g IV every 6–8 hours

• Children: Dose based on body weight, under physician guidance

• Administer via intravenous infusion over 20–30 minutes

• Dosage adjustment may be required in renal impairment

• Reconstitute with sterile water or appropriate IV diluent

• Administer under medical supervision in sterile conditions

• Complete full course even if symptoms improve early

• Do not mix with other drugs in the same IV line unless confirmed compatible

• Hypersensitivity to penicillins or cephalosporins

• Caution in patients with renal dysfunction or electrolyte imbalance

• Monitor liver enzymes and blood counts during prolonged therapy

• Not recommended in viral infections (e.g., influenza)

• Diarrhea

• Injection site reactions

• Nausea or vomiting

• Elevated liver enzymes

• Rare: Hypersensitivity reactions, thrombocytopenia

• Form: Dry powder for IV injection

• Strengths: 4.5 g / 2.25 g / 1.125 g

• Pack Type: Glass vial with sterile water for injection (if required)

• Shelf Life: 24 months

• Storage: Store below 25°C; protect from light and moisture

• Certifications: WHO-GMP, ISO 9001:2015, FDA (India)

BLUEPILL EXPRESS – A global leader in third-party pharmaceutical manufacturing and merchant export of high-quality medical formulations. Backed by state-of-the-art infrastructure and international certifications, BLUEPILL EXPRESS is committed to quality, safety, and efficacy in healthcare exports.

• WHO-GMP certified global manufacturing facility

• Customizable formulations and labeling for clients

• Strict adherence to international pharmacopeial standards

• Available for bulk export, contract manufacturing, and tender supply

• Supported with complete COA, MSDS, and export documentation